Similar articles for PMID: 20728948

Year	Number of Results
1952	1
1993	1
1997	2
2000	1
2002	1
2003	2
2004	3
2005	3
2006	6
2007	8
2008	12
2009	10
2010	13
2011	15
2012	18
2013	10
2014	8
2015	8
2016	12
2017	4
2018	7
2019	5
2020	4
2021	2
2022	4
2023	1
2024	0

1

Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study.

Yamout B, Hourani R, Salti H, Barada W, El-Hajj T, Al-Kutoubi A, Herlopian A, Baz EK, Mahfouz R, Khalil-Hamdan R, Kreidieh NM, El-Sabban M, Bazarbachi A. Yamout B, et al. J Neuroimmunol. 2010 Oct 8;227(1-2):185-9. doi: 10.1016/j.jneuroim.2010.07.013. Epub 2010 Aug 21. J Neuroimmunol. 2010. PMID: 20728948 Clinical Trial.

2

Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study.

Mohyeddin Bonab M, Yazdanbakhsh S, Lotfi J, Alimoghaddom K, Talebian F, Hooshmand F, Ghavamzadeh A, Nikbin B. Mohyeddin Bonab M, et al. Iran J Immunol. 2007 Mar;4(1):50-7. Iran J Immunol. 2007. PMID: 17652844 Free article. Clinical Trial.

3

Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study.

Pal R, Venkataramana NK, Bansal A, Balaraju S, Jan M, Chandra R, Dixit A, Rauthan A, Murgod U, Totey S. Pal R, et al. Cytotherapy. 2009;11(7):897-911. doi: 10.3109/14653240903253857. Cytotherapy. 2009. PMID: 19903102 Clinical Trial.

4

Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease.

Venkataramana NK, Kumar SK, Balaraju S, Radhakrishnan RC, Bansal A, Dixit A, Rao DK, Das M, Jan M, Gupta PK, Totey SM. Venkataramana NK, et al. Transl Res. 2010 Feb;155(2):62-70. doi: 10.1016/j.trsl.2009.07.006. Epub 2009 Aug 6. Transl Res. 2010. PMID: 20129486 Clinical Trial.

5

Safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis.

Rice CM, Mallam EA, Whone AL, Walsh P, Brooks DJ, Kane N, Butler SR, Marks DI, Scolding NJ. Rice CM, et al. Clin Pharmacol Ther. 2010 Jun;87(6):679-85. doi: 10.1038/clpt.2010.44. Epub 2010 May 5. Clin Pharmacol Ther. 2010. PMID: 20445531 Clinical Trial.

6

Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosis.

Harris VK, Vyshkina T, Sadiq SA. Harris VK, et al. Cytotherapy. 2016 Dec;18(12):1476-1482. doi: 10.1016/j.jcyt.2016.08.007. Epub 2016 Oct 7. Cytotherapy. 2016. PMID: 27727015

7

Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.

Fassas A, Passweg JR, Anagnostopoulos A, Kazis A, Kozak T, Havrdova E, Carreras E, Graus F, Kashyap A, Openshaw H, Schipperus M, Deconinck E, Mancardi G, Marmont A, Hansz J, Rabusin M, Zuazu Nagore FJ, Besalduch J, Dentamaro T, Fouillard L, Hertenstein B, La Nasa G, Musso M, Papineschi F, Rowe JM, Saccardi R, Steck A, Kappos L, Gratwohl A, Tyndall A, Samijn J; Autoimmune Disease Working Party of the EBMT (European Group for Blood and Marrow Transplantation). Fassas A, et al. J Neurol. 2002 Aug;249(8):1088-97. doi: 10.1007/s00415-002-0800-7. J Neurol. 2002. PMID: 12195460 Clinical Trial.

8

Case control series of intrathecal autologous bone marrow mesenchymal stem cell therapy for chronic spinal cord injury.

Kishk NA, Gabr H, Hamdy S, Afifi L, Abokresha N, Mahmoud H, Wafaie A, Bilal D. Kishk NA, et al. Neurorehabil Neural Repair. 2010 Oct;24(8):702-8. doi: 10.1177/1545968310369801. Epub 2010 Jul 26. Neurorehabil Neural Repair. 2010. PMID: 20660620

9

High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis.

Shevchenko YL, Novik AA, Kuznetsov AN, Afanasiev BV, Lisukov IA, Kozlov VA, Rykavicin OA, Ionova TI, Melnichenko VY, Fedorenko DA, Kulagin AD, Shamanski SV, Ivanov RA, Gorodokin G. Shevchenko YL, et al. Exp Hematol. 2008 Aug;36(8):922-8. doi: 10.1016/j.exphem.2008.03.001. Epub 2008 May 12. Exp Hematol. 2008. PMID: 18468768 Free article. Clinical Trial.

10

Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium.

Katritsis DG, Sotiropoulou PA, Karvouni E, Karabinos I, Korovesis S, Perez SA, Voridis EM, Papamichail M. Katritsis DG, et al. Catheter Cardiovasc Interv. 2005 Jul;65(3):321-9. doi: 10.1002/ccd.20406. Catheter Cardiovasc Interv. 2005. PMID: 15954106 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

136 results

Results by year